EBStatMax: State-of-the-art statistical design and analysis for maximal success with minimal patient burden in Epidermolysis bullosa trials | PI: EB Haus

Research co-operation with the University Clinic for Dermatology and Allergology (SALK) / EB House (project management), University of Hasselt, KU Leuven, Uppsala University and the Paracelsus Medical University Salzburg (PMU) | funded by the European Joint Programme on Rare Diseases | application-oriented basic research